TLDR Lack of vitamin D receptor increases skin tumor risk by boosting hedgehog signaling.
The study explored the role of the vitamin D receptor (VDR) in skin tumor formation, focusing on the hedgehog (Hh) signaling pathway. VDR-null mice showed increased skin tumor formation when exposed to carcinogens, with overexpression of Hh pathway components. The absence of VDR led to hyperproliferation and decreased differentiation in the epidermis, predisposing the skin to tumors. Treatment with 1,25 dihydroxyvitamin D3 downregulated some Hh pathway members, indicating that VDR and its ligand played a protective role against skin carcinogenesis by regulating the Hh pathway.
53 citations
,
May 2010 in “Journal of Cellular Physiology” Mice without Vitamin D receptors have hair growth problems because of issues in the hedgehog signaling pathway.
148 citations
,
May 2008 in “The journal of investigative dermatology/Journal of investigative dermatology” Mice without the vitamin D receptor are more prone to UV-induced skin tumors.
427 citations
,
April 2008 in “Nature Protocols” 127 citations
,
January 2008 in “PloS one” Vitamin D receptor helps control hair growth and could be used to treat certain skin tumors.
81 citations
,
January 2006 in “Journal of cellular physiology” Mice without the vitamin D receptor gene lose hair due to disrupted hair follicle cycles.
92 citations
,
May 2004 in “Journal of Investigative Dermatology” 180 citations
,
January 2002 in “The journal of investigative dermatology/Journal of investigative dermatology” Vitamin D Receptor is crucial for normal skin and hair growth.
380 citations
,
March 2000 in “Proceedings of the National Academy of Sciences” Overexpressing GLI-1 in mice skin can cause tumors like human basal cell carcinomas.
333 citations
,
March 2000 in “Proceedings of the National Academy of Sciences” Overexpressing GLI-1 in mice skin can cause tumors like human basal cell carcinomas.
November 2011 in “Molecular Cancer Therapeutics” The Hedgehog signaling pathway is linked to cancer development, and targeting it with inhibitors shows promise but faces challenges like resistance.